Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

A dendritic cell vaccine induces CEA-specific immune responses in cancer patients

May 11, 2005

Viragen licenses anti-CD55 antibody from Cancer Research Technology

May 11, 2005

BioVex submits IND for OncoVex(GM-CSF) in malignant melanoma

May 6, 2005

Chugai develops an apoptosis-inducing antibody for multiple myeloma / News in context

May 6, 2005

105AD7 vaccine demonstrates activity in osteosarcoma patients

May 4, 2005

GSK will not negotiate HER-2 Protein AutoVac vaccine deal

May 3, 2005

Updated survival data reported from phase I study of IL13-PE38QQR

May 3, 2005

Data from the HERA study support the use of Herceptin in early breast cancer

May 3, 2005

CR-064 neutralizes procancerous actions of ARP4

April 29, 2005

Dosing under way in phase I/II trial of ImmunoVEX-Trimelan

April 29, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...